Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL) Loans Receivable: ₺0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

IST:GENIL Gen Ilac Ve Saglik Urunleri Sanayi ve Ticaret AS IST:GENIL
86 GF Score
Price ₺9.38
GF Value ₺8.19
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Gen Ilac Veglik Urunlerinayi ve Ticaret AS Loans Receivable?

Gen Ilac Veglik Urunlerinayi ve Ticaret AS IST:GENIL +4.11% 86 Loans Receivable is ₺0 Mil as of Mar. 2026. GuruFocus rates IST:GENIL with a GF Score™ of 86/100 and a GF Value™ of ₺8.19 (Modestly Overvalued). The stock has 5 warning signs investors should review.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Loans Receivable for the quarter that ended in Mar. 2026 was ₺0 Mil.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS Loans Receivable Related Terms

Gen Ilac Veglik Urunlerinayi ve Ticaret AS Loans Receivable Historical Data

* Premium members only.

The historical data trend for Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS Loans Receivable Chart

Gen Ilac Veglik Urunlerinayi ve Ticaret AS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Loans Receivable
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Gen Ilac Veglik Urunlerinayi ve Ticaret AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
IST:GENIL
86GF Score
Gen Ilac Ve Saglik Urunleri Sanayi ve Ticaret AS IST:GENIL
Loans Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gen Ilac Veglik Urunlerinayi ve Ticaret AS Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.

Frequently Asked Questions Learn more about Loans Receivable →
What does a Loans Receivable of ₺0 Mil mean?
Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL) has a Loans Receivable of ₺0 Mil as of Mar. 2026. Loans Receivable are the funds that a company has lent but have not yet been repaid. View historical data on Gen Ilac Veglik Urunlerinayi ve Ticaret AS and its competitors.
Is Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Loans Receivable too high?
Gen Ilac Veglik Urunlerinayi ve Ticaret AS's current Loans Receivable is ₺0 Mil. Overall, Gen Ilac Veglik Urunlerinayi ve Ticaret AS has a GF Score™ of 86/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Loans Receivable compare to ZTS and UTHR?
Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Loans Receivable of ₺0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Loans Receivable for a Drug Manufacturers company?
A good Loans Receivable depends on the Drug Manufacturers industry context. However, Loans Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Loans Receivable mean?
A high Loans Receivable can signal that a stock is expensive relative to its fundamentals. Loans Receivable are the funds that a company has lent but have not yet been repaid. View historical data on Gen Ilac Veglik Urunlerinayi ve Ticaret AS and its competitors. Gen Ilac Veglik Urunlerinayi ve Ticaret AS's current Loans Receivable is ₺0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gen Ilac Veglik Urunlerinayi ve Ticaret AS stock overvalued right now?
Based on GuruFocus' analysis, Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL) is currently considered Modestly Overvalued. The stock's GF Value™ is ₺8.19, compared to a current price of ₺9.38 — trading 14.5% above its estimated fair value. The current Loans Receivable is ₺0 Mil. Gen Ilac Veglik Urunlerinayi ve Ticaret AS's overall GF Score™ is 86/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Loans Receivable calculated?
Loans Receivable is calculated from a company's financial statements. For Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL), the current Loans Receivable is ₺0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL) Overvalued in 2026?

Based on GuruFocus' analysis, Gen Ilac Veglik Urunlerinayi ve Ticaret AS stock appears to be overvalued. The current stock price of ₺9.38 is trading 14.5% above its estimated GF Value™ of ₺8.19. GuruFocus considers Gen Ilac Veglik Urunlerinayi ve Ticaret AS to be Modestly Overvalued.

Key valuation signals for IST:GENIL:

  • Loans Receivable: ₺0 Mil
  • GF Value™: ₺8.19 vs. price of ₺9.38 (14.5% above fair value)
  • GF Score™: 86/100 with 5 warning signs

No single metric tells the full story. See the IST:GENIL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS Business Description

Address Mustafa Kemal Mahallesi 2119.Sk. No:3, Cankaya, Ankara, TUR, 06520
Gen Ilac Ve Saglik Urunleri Sanayi ve Ticaret AS is a specialty pharmaceuticals company in Turkey. Its locally manufactured products include Cajex, Contra-K, Epamor, Genkort, Ilopera, among others, while imported products include AvonexPEN, Plegridy, Tecfidera, Regen-D among others.
86GF Score

Get the complete analysis for IST:GENIL

Loans Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₺9.38
Price
₺8.19
GF Value